Treatment of Hodgkin's Disease: The Swedish National Care Programme Experience
- 1 January 1996
- journal article
- clinical trial
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 21 (1-2) , 71-78
- https://doi.org/10.3109/10428199609067582
Abstract
Since 1985 a Swedish National Care Programme has provided tailored principles for the diagnosis, staging, treatment and follow-up of patients with Hodgkin's disease (HD). This report gives the rationale behind the recommendations and presents treatment results for 648 patients diagnosed between 1985 and 1989 after a median follow-up of 70 months. Two hundred and twenty-nine (35%) patients were over 60 years of age. Treatment results for patients below 60 years of age in early and intermediate stages were favourable, provided the recommendations were followed. In advanced stages, the outcome was inferior in patients with CS IIB bulky disease and stage IVB. The prognosis of elderly patients remains poor, although it is too early to evaluate any impact of revisions made in 1989. The tailored principles, which usually entail less staging and/or treatment than is generally the case in the early and intermediate stages, produced favourable results when applied to an unselected group of patients with HD. Only minor changes were made in the recommendations during the 1994 revision.Keywords
This publication has 17 references indexed in Scilit:
- Hodgkin's DiseaseNew England Journal of Medicine, 1993
- Radiotherapy versus combined modality in early stagesAnnals of Oncology, 1992
- Hodgkin's DiseaseNew England Journal of Medicine, 1992
- Treatment outcome in Hodgkin's disease in patients above the age of 60: A population-based studyAnnals of Oncology, 1991
- Hodgkin's Disease in Northern Sweden 1971-1981. III. The Clinical and Prognostic Impact of AgeActa Oncologica, 1991
- Salvage chemotherapy in Hodgkin's diseaseAnnals of Oncology, 1990
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.Journal of Clinical Oncology, 1989
- MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.Journal of Clinical Oncology, 1987
- Hodgkin's disease: Is there a price for successful treatment? A 25-year experienceInternational Journal of Radiation Oncology*Biology*Physics, 1986